Print 
Share 
Text 
To reset, hold the Ctrl key, then press 0.
Patient Cathy Chapman (left) and her sister, Enid Holohan, discussed her clinical trial treatment with Clinical Research Coordinator Saara Ali (right).
Chemotherapy wasn’t working for Cathy Chapman. However, a genetic test identified a specific gene mutation that meant she could take part in a new cancer drug trial.
Chapman was diagnosed with colon cancer in February 2017. She began chemotherapy at The Ottawa Hospital’s satellite clinic in Pembroke, since she lives in Deep River. However, the chemotherapy did nothing but give her side effects. The cancer continued growing, so her treatment stopped in April 2017.
Meanwhile, The Ottawa Hospital’s Molecular Oncology Diagnostics Laboratory analyzed Chapman’s tumour and identified a gene mutation that offered another treatment option. Only about five percent of colon cancers have this mutation. Dr. Bryan Lo, director of the molecular lab, flagged the mutation to Chapman’s oncologist, Dr. Rachel Goodwin.
Dr. Goodwin knew about an upcoming international clinical trial at The Ottawa Hospital Cancer Centre for a drug that was having great success with Chapman’s specific sub-type of colon cancer. The drug was designed to block the mutation and slow down the cancer growth.
Oncologist Dr. Rachel Goodwin identified a clinical trial that would treat Cathy Chapman’s rare type of colon cancer.
Chapman was the first patient in Canada on this international trial.
In 2016, the molecular lab began analyzing the genetic makeup of colon cancer tumours using its new Next Generation Sequencer (purchased entirely with donor support). By identifying the genetic makeup of each person’s individual tumour, oncologists can tailor the cancer treatment to be more effective for them.
“When we get the genetic sequencing report back for a colon cancer patient, we might see that the patient has a gene mutation that could make their cancer susceptible to a drug we never would have considered, like a kidney cancer drug, or to a new drug,” said Dr. Goodwin. This was the case with 60-year-old Chapman.
“Because there is currently no drug being used as a standard of care for her type of colon cancer, Cathy could get the drug only on a trial,” said Dr. Goodwin. “That is why we take the efforts to open new trials here with new drugs to provide patients like Cathy with up and coming treatments.”
Cathy Chapman visits The Ottawa Hospital Cancer Centre for weekly treatments as part of a clinical trial.
“Cathy wasn’t doing so well on her other treatments, so the timing was perfect that this trial was coming up,” said Saara Ali, Clinical Research Coordinator. “Thanks to the molecular testing done by Dr. Lo and the networking between him, Dr. Goodwin, and myself, we were able to put forward this new patient for this clinical trial as a treatment option.”
“I was randomized into the trial, which gives me multiple drugs,” said Chapman, who drives to the Cancer Centre at the General Campus once a week for treatment. “Within several doses, the CT scan showed a reduction in my cancer. The tumour shrank 40 percent after I was on the clinical trial for seven weeks. In December, a CT scan showed it had shrunk 63 percent.”
“She’s at full dose and doing well on it,” said Ali. “As long as she is benefitting, the drugs will be provided for her through the clinical trial.”
The molecular lab is prepared to identify mutations in the genetic profile of other patients with this rare mutation, so they might also take part in the trial and benefit from trying innovative and untested therapies.
The Ottawa Hospital is raising funds that are critical for research studies and clinical trials in order to bring better treatments to patients as soon as they are available.
Support patient care and research at
The Ottawa Hospital
You might also like…
Looking to get screened for cancer but don’t have a family doctor? Make an appointment with our “Superscreener”
Regular cancer screening can help save lives. For people living in Eastern Ontario who do not have a primary care provider, the Champlain Screening Outreach Program offers screening services for breast, cervical, colorectal and lung cancer. Find out how to book your appointment with Nurse Practitioner Sarah Junkin-Hepworth, our “Superscreener.”
Patient gifts a piece of home to Indigenous Cancer Program
Inuit patients can now see and hold a piece of their traditional territory in the Windòcàge Room at the General Campus, thanks to an interactive gift donated to The Ottawa Hospital by a cancer patient.
A team from The Ottawa Hospital helps organize first-ever oncology conference in the North
When it comes to cancer treatment, there’s no place like home. This spring, a team from The Ottawa Hospital helped organize Nunavut’s first-ever oncology conference to figure out how to bring oncology care closer to home for patients.
New Research Chair in Gay Men’s Health is setting out to break down barriers to care
As both a researcher and a gay man, Dr. Paul MacPherson knows all too well the stigma that gay men often face in the health-care system. Now, as the Clinical Research Chair in Gay Men’s Health at The Ottawa Hospital and the University of Ottawa, he’s on a mission to make quality health care more accessible to this often overlooked patient population.
Made-in-Ottawa tool helps decide when critically ill patients can breathe on their own
Over the past two years of the pandemic, more Canadians than ever have required mechanical ventilation to help them breathe. The Ottawa Hospital is the first hospital in the world to evaluate an innovative medical device that uses artificial intelligence to predict when critically ill patients are ready to breathe on their own.
Getting screened for colon cancer is fast, easy and free
Poop, #2, BM, stool – whatever you call it, it could save your life. The screening test for colon cancer is quick, free, painless, and can be done from home. Get checked today, because nine out of 10 people can be cured if colon cancer is caught early.
Comment on this post